Clinical-stage biotechs can be veritable goldmines for patient investors. The caveat, however, is that it can immensely difficult to predict which companies are actually worth the wait.
Where Will Cara Therapeutics, Inc. Be in 5 Years?
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться